ESMO 2018: Highlights
ESMO 2018: Highlights
Comment on new treatment options for breast cancer
Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1
Results from the IMpassion130 trial for triple-negative breast cancer
Results from the SOLAR-1 trial for advanced breast cancer
PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer
Results from the PALOMA-3 trial for advanced breast cancer
New therapeutic options in advanced and metastatic breast cancer
The political and social determinants for breast cancer patients in the Gaza Strip
The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer
The 'My Health Avatar' app for iManageCancer
21st century medicine is transforming healthcare and the diagnosis and treatment of cancer